Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Plos One|October 14, 2015
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome StudyHelle H Nielsen, Hans C Beck, Lars P Kristensen, et al.
Frontiers in Immunology|September 20, 2024
Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients-a longitudinal cohort studyFrederik Novak, Anna Christine Nilsson, Emil Birch Christensen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Extended interval dosing with ocrelizumab in multiple sclerosisFrederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard, et al.
Frontiers in Neurology|April 30, 2025
A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy: Study 512Sergey Burd, Giovanni Assenza, Sofia Quintas, et al.
Scientific Reports|February 19, 2021
CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomesMaria L Elkjaer, Arkadiusz Nawrocki, Tim Kacprowski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 2024
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in DenmarkElisabeth Framke, Finn Sellebjerg, Matthias Kant, et al.
Multiple Sclerosis and Related Disorders|March 25, 2022
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patientsHamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, et al.
Frontiers in Immunology|May 10, 2018
Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)Morten Blaabjerg, Anne Louise Hemdrup, Lylia Drici, et al.
Journal of the Neurological Sciences|June 19, 2022
MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosisSimone Hjæresen, Tobias Sejbaek, Markus Axelsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2024
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish studyMie Reith Mahler, Melinda Magyari, Luigi Pontieri, et al.
Pageof 4